Electrocore LLC (ECOR) - Net Assets
Based on the latest financial reports, Electrocore LLC (ECOR) has net assets worth $-5.69 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($15.48 Million) and total liabilities ($21.17 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible net worth ratio of Electrocore LLC to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-5.69 Million |
| % of Total Assets | -36.74% |
| Annual Growth Rate | N/A |
| 5-Year Change | -104.66% |
| 10-Year Change | N/A |
| Growth Volatility | 52.85 |
Electrocore LLC - Net Assets Trend (2016–2025)
This chart illustrates how Electrocore LLC's net assets have evolved over time, based on quarterly financial data. See ECOR defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Electrocore LLC (2016–2025)
The table below shows the annual net assets of Electrocore LLC from 2016 to 2025. For live valuation and market cap data, see ECOR stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $-1.71 Million | -122.65% |
| 2024-12-31 | $7.54 Million | +1.37% |
| 2023-12-31 | $7.44 Million | -56.44% |
| 2022-12-31 | $17.09 Million | -53.38% |
| 2021-12-31 | $36.65 Million | +55.00% |
| 2020-12-31 | $23.64 Million | -5.03% |
| 2019-12-31 | $24.90 Million | -62.38% |
| 2018-12-31 | $66.19 Million | +173.98% |
| 2017-12-31 | $-89.47 Million | -46.54% |
| 2016-12-31 | $-61.05 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Electrocore LLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 9034958100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $8.00K | % |
| Other Comprehensive Income | $99.00K | % |
| Other Components | $189.24 Million | % |
| Total Equity | $-1.71 Million | 100.00% |
Electrocore LLC Competitors by Market Cap
The table below lists competitors of Electrocore LLC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
WooriNet Inc
KQ:115440
|
$72.13 Million |
|
E & M Computing Ltd
TA:EMCO
|
$72.13 Million |
|
Cypherpunk Technologies Inc.
NASDAQ:CYPH
|
$72.15 Million |
|
Globe International Ltd
AU:GLB
|
$72.17 Million |
|
Global View Co Ltd
TW:3040
|
$72.12 Million |
|
Subex Limited
NSE:SUBEXLTD
|
$72.07 Million |
|
Hyundai E P
KO:089470
|
$72.05 Million |
|
Consolidated Construction Consortium Limited
NSE:CCCL
|
$72.04 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Electrocore LLC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 7,544,000 to -1,709,000, a change of -9,253,000 (-122.7%).
- Net loss of 13,966,000 reduced equity.
- New share issuances of 217,000 increased equity.
- Other comprehensive income decreased equity by 15,000.
- Other factors increased equity by 4,511,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-13.97 Million | -817.2% |
| Share Issuances | $217.00K | +12.7% |
| Other Comprehensive Income | $-15.00K | -0.88% |
| Other Changes | $4.51 Million | +263.96% |
| Total Change | $- | -122.65% |
Book Value vs Market Value Analysis
This analysis compares Electrocore LLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | $-6.08 | $8.70 | x |
| 2017-12-31 | $-13.90 | $8.70 | x |
| 2018-12-31 | $33.60 | $8.70 | x |
| 2019-12-31 | $12.39 | $8.70 | x |
| 2020-12-31 | $8.85 | $8.70 | x |
| 2021-12-31 | $9.29 | $8.70 | x |
| 2022-12-31 | $3.61 | $8.70 | x |
| 2023-12-31 | $1.35 | $8.70 | x |
| 2024-12-31 | $1.01 | $8.70 | x |
| 2025-12-31 | $-0.20 | $8.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Electrocore LLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -43.60%
- • Asset Turnover: 1.72x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-96.08%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.00% | -6192.44% | 0.41x | 0.00x | $-9.63 Million |
| 2017 | 0.00% | -4410.88% | 0.02x | 0.00x | $-26.79 Million |
| 2018 | -85.16% | -5621.66% | 0.01x | 1.12x | $-62.38 Million |
| 2019 | -186.09% | -1888.81% | 0.07x | 1.46x | $-47.57 Million |
| 2020 | -102.18% | -672.55% | 0.11x | 1.37x | $-25.81 Million |
| 2021 | -46.98% | -315.87% | 0.13x | 1.17x | $-20.88 Million |
| 2022 | -129.71% | -257.94% | 0.35x | 1.45x | $-23.87 Million |
| 2023 | -253.08% | -117.49% | 1.00x | 2.16x | $-19.58 Million |
| 2024 | -157.56% | -47.20% | 1.23x | 2.71x | $-12.64 Million |
| 2025 | 0.00% | -43.60% | 1.72x | 0.00x | $-13.80 Million |
Industry Comparison
This section compares Electrocore LLC's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,818,520,110
- Average return on equity (ROE) among peers: -48.87%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Electrocore LLC (ECOR) | $-5.69 Million | 0.00% | N/A | $72.13 Million |
| Abbott Laboratories (ABT) | $17.78 Billion | 20.28% | 1.23x | $153.89 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $19.91 Million | -270.00% | 1.43x | $15.55 Million |
| Aethlon Medical Inc (AEMD) | $-5.98 Million | 0.00% | 0.00x | $2.51 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $903.35K |
| Adapthealth Corp (AHCO) | $280.85 Million | -57.55% | 5.46x | $1.29 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $6.89 Million | 30.07% | 0.49x | $6.67 Million |
| Allurion Technologies, Inc. (ALUR) | $-70.49 Million | 0.00% | 0.00x | $7.70 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $8.10 Million | -140.88% | 0.21x | $4.44 Million |
| Artivion Inc (AORT) | $17.90 Million | 7.26% | 0.20x | $1.03 Billion |
| Apyx Medical Inc (APYX) | $22.89 Million | 2.69% | 0.23x | $176.29 Million |
About Electrocore LLC
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic… Read more